Skip to main content
. 2014 Jan 20;15:26. doi: 10.1186/1471-2474-15-26

Figure 2.

Figure 2

Results from 1,000 model simulations. Upper panel: incremental cost and QALYs for etanercept plotted on cost-effectiveness plane; lower panel: percentage of simulations where treatment has highest net monetary benefit at varying WTP thresholds.